Roxadustat as treatment for a blood transfusion-dependent maintenance hemodialysis patient: A case report and review of literature

doi:10.12998/wjcc.v9.i15.3680

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 15

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5548)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

286

WORD

160

HTML

3144

Figures (1-3)

289

Tables (1-2)

239

Sum=4118

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

493

Download

937

Sum=1430

May 26, 2021 (publication date) through Nov 20, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. May 26, 2021; 9(15): 3680-3688
Published online May 26, 2021. doi: 10.12998/wjcc.v9.i15.3680

Full Size Figure Download Figure

Figure 1 Changes in hemoglobin and reticulocyte count after oral administration of Roxadustat. Hb: Hemoglobin; RET: Reticulocyte.

Citation: Fei M, Wen XQ, Yu ZL, Kang T, Wu WH, Ou ST. Roxadustat as treatment for a blood transfusion-dependent maintenance hemodialysis patient: A case report and review of literature. World J Clin Cases 2021; 9(15): 3680-3688
URL: https://www.wjgnet.com/2307-8960/full/v9/i15/3680.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i15.3680